Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Icagen Inc (ICGN) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Icagen Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 902622.
Total stock buying since 2010: $49,620,644.
Total stock sales since 2010: $672.
Total stock option exercises since 2010: $116,652.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2011 | 8,268,473 | $49,611,344 | 113 | $672 | 42,910 | $116,652 |
2010 | 25,000 | $9,300 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2011-10 | 2,743,269 | $16,459,614 | 0 | $0 | 0 | $0 |
2011-09 | 5,525,204 | $33,151,730 | 0 | $0 | 42,910 | $116,652 |
2011-08 | 0 | $0 | 113 | $672 | 0 | $0 |
2010-08 | 25,000 | $9,300 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-10-27 | Eclipse Acquisition Corp. (10% Owner) | Buy | 2,743,269 | 6.00 | 16,459,614 |
2011-09-19 | Eclipse Acquisition Corp. (10% Owner) | Buy | 61,083 | 6.00 | 366,498 |
2011-09-16 | Eclipse Acquisition Corp. (10% Owner) | Buy | 5,536 | 6.00 | 33,216 |
2011-09-15 | Eclipse Acquisition Corp. (10% Owner) | Buy | 232,203 | 6.00 | 1,393,218 |
2011-09-12 | Eclipse Acquisition Corp. (10% Owner) | Buy | 422,023 | 6.00 | 2,532,138 |
2011-09-09 | Eclipse Acquisition Corp. (10% Owner) | Buy | 60,121 | 6.00 | 360,726 |
2011-09-08 | Eclipse Acquisition Corp. (10% Owner) | Buy | 493 | 6.00 | 2,958 |
2011-09-07 | Lampert Mark N | Buy | 126,700 | 6.00 | 760,706 |
2011-09-02 | Simonetti Martin A (Director) | Option Ex | 4,500 | 3.33 | 14,998 |
2011-09-02 | Olukotun Adeoye Y (Director) | Option Ex | 4,500 | 3.33 | 14,998 |
2011-09-02 | Evnin Anthony B (Director) | Option Ex | 7,910 | .00 | 0 |
2011-09-02 | Pfizer Inc (10% Owner) | Buy | 4,617,045 | 6.00 | 27,702,270 |
2011-09-01 | Evnin Anthony B (Director) | Option Ex | 5,500 | 3.33 | 18,331 |
2011-09-01 | Morrison Richard G (Director) | Option Ex | 4,500 | 3.33 | 14,998 |
2011-09-01 | Lamotte Andre (Director) | Option Ex | 4,500 | 3.33 | 14,998 |
2011-09-01 | Sanders Charles A (Director) | Option Ex | 11,500 | 3.33 | 38,329 |
2011-08-18 | Katz Richard D (Ex VP, Fin & Corp, CFO & Treas) | Sale | 8 | 5.96 | 47 |
2011-08-10 | Katz Richard D (Ex VP, Fin & Corp, CFO & Treas) | Sale | 36 | 5.96 | 214 |
2011-08-10 | Wagoner Kay (President and CEO) | Sale | 69 | 5.96 | 411 |
2010-08-17 | Wagoner Kay (President and CEO) | Buy | 25,000 | .37 | 9,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of ICGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Icagen Inc (symbol ICGN, CIK number 902622) see the Securities and Exchange Commission (SEC) website.